Vibration Response Imaging (VRI) in Lung Transplant Recipients

NCT ID: NCT00744822

Last Updated: 2008-09-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

55 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-03-31

Study Completion Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a prospective, multi-center study. 50 lung transplant recipients will be enrolled in the study. Subjects will be selected from lung transplant recipients, who have undergone single or double lung transplantation during the last six months These patients will undergo a baseline VRI recording prior to the interventional procedure and a follow-up VRI at 1 hour after the interventional procedure. Furthermore, the patients will be recorded at the designated follow-up periods of 1, 3 and 6-month (+ 7 days) post-baseline visit, as well as before and 1 hour after any recurrent interventional procedure

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Study participants will be patients who have undergone lung transplantation during the last 6 months and are in a stable clinical position at the time of enrollment.
* Patients who meet the study inclusion and exclusion criteria will be enrolled in the study.
* The enrolled patients will be recorded with the VRI at each occurrence in which the standard procedures are performed:

* Baseline after study enrollment (VRI Recording 1 + standard evaluations).
* At each follow-up visit \[1, 3, 6 months after baseline visit\] during the 6 month follow-up period of the study (VRI Recordings + standard evaluations (if possible)).
* In the event of bronchoscopic intervention, then before the interventional procedure (VRI Recording 1 + standard evaluations) and before any recurrent interventional procedures (VRI Recordings + standard evaluations) during the course of the study (6-month follow-up period).
* 1 hour after all bronchoscopic interventional procedures.
* In the event of an unanticipated visit, then a VRI recording will be performed (VRI Recordings + standard evaluations).
* All subjects will be recorded according to a standard procedure; moreover, it is essential that for each subject repeatable recordings will be performed in the same manner (i.e. breathing manner and matrix placement). Each VRI recording session will take \~15 minutes \[the actual recording is \~2 minutes for placement and breathing/recording\].
* Standard evaluation procedures may include any of the following:

* Lung function tests (this test is required at all visits)
* Physical examination
* Bronchoscopy (e.g. transbronchial biopsy)
* CT-imaging
* Chest x-ray
* V/Q Scan (Baseline visit for single lung transplantation)
* Blood gases (this test is required at all visits)
* Blood tests

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Transplantation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Lung Transplantation Infections Graft Rejection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Able and willing to read, understand, and provide written Informed Consent
2. Male or Female in the age range of 18-65 years
3. Subject is a lung transplant recipient who underwent single or double lung transplantation within the last 6 months
4. BMI \> 19
5. Height of \>1.55 meters
6. Stable clinical condition at study baseline evaluation

Exclusion Criteria

Any of the following will exclude the subject from study:

1. Intubated patients
2. Chest wall deformation
3. Spine deformation (including severe scoliosis)
4. Hirsutism
5. Potentially contagious skin lesion on the back
6. Skin lesion that would interfere with sensor placement
7. Cardiac pacemaker or implantable defibrillator
8. Patient is pregnant as confirmed with urine pregnancy test
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Deep Breeze

INDUSTRY

Sponsor Role collaborator

Hannover Medical School

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Deep Breeze Ltd.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tobias Welte, MD

Role: PRINCIPAL_INVESTIGATOR

Hannover Medical School

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hannover Medical School

Hanover, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4066

Identifier Type: -

Identifier Source: org_study_id